// App-Quantinova.ai

: Results from a Prospective, Multicenter, Dose Escalating, Prophylaxis Study in Young Boys with Severe Haemophilia A in China: The China Haemophilia Individualized Prophylaxis Study (CHIPS) (NCT02999308)

Researchers

Presenter

  • R. Wu

Principal Investigators

  • Q. Zhang

  • X. Luo

  • L. Tang

  • M. Zhou

  • Y. Wang

  • P. Ding

  • N. Zhang

  • S. Yang

  • P. Hilliard

  • K. Usuba

  • N.L. Young

  • A.S. Doria

  • A. Abad

  • Z. Chen

  • Y. Peng

  • K.-H. Luke

  • V.S. Blanchette

  • X. Li

Medical Centers

  • Capital Medical University, Beijing Children's Hospital, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Beijing, China

  • New Century Children's Hospital, Department of Hematology, Chengdu, China

  • Capital Medical University, Beijing Chao-yang Hospital, Beijing, China

  • Chengdu Women and Children Central Center Hospital, Hematology, Chengdu, China

  • Capital Medical University, Beijing Children's Hospital, Hematology Department, Beijing, China

  • The Hospital for Sick Children, Department of Rehabilitation Medicine, Toronto, Canada

  • Laurentian University, School of Rural and Northern Health and the Research Centre for Evaluating Children's Health Outcomes (ECHO), Sudbury, Canada

  • Hospital for Sick Children, Division of Gastroenterology, Toronto, Canada

  • The Hospital for Sick Children, Child Health Evaluative Sciences, Research Institute, Toronto, Canada

  • University of Ottawa Children Hospital of Eastern Ontario, Division of Hematology and Oncology,Department of Pediatrics, Laboratory Medicine and Pathology, Ottawa, Canada

  • Hospital for Sick Children, Division of Gastroenterology, Toronto, Canada

  • New Century Children's Hospital, Department of Hematology, Chengdu, China

Locations

  • China

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

Outcome

  • N/A


Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A